Product Images Ranolazine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Ranolazine NDC 69097-222 by Cipla Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
7141ddf2 9c11 4d86 a0b3 ec7fd7e035b0 01
7141ddf2 9c11 4d86 a0b3 ec7fd7e035b0 02
This is a description for a medication called Ranolazine. It is an extended-release tablet that should be swallowed whole and not be crushed or chewed. The package contains 30 tablets, and the dosage should be determined by a healthcare professional. This medication is only available with a prescription. The text also includes some misprints and symbols that were not converted correctly into text.*
7141ddf2 9c11 4d86 a0b3 ec7fd7e035b0 03
Ranolazine is an extended-release medication available in tablet form. Each film-coated tablet contains 1,000mg of Ranolazine. It is important to swallow the whole tablet without breaking, crushing or chewing it. The package is child-resistant, and the tablets should be stored at a temperature between 15-30°C. The manufacturer of these tablets is Cipla Ltd., Indore SEZ, Pithampur, India. The package insert provides information on the usual dosage and administration. The product is only available on a prescription basis.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.